Translational Neuroimaging Laboratory (TNL) develops neuroimaging techniques and analytical frameworks for modeling neurodegenerative processes including deposition of protein aggregates, metabolic abnormalities, cell transport systems and neuroreceptors dysfunction. The laboratory encompasses a cohesive multidisciplinary team conducting integrative and multimodal neuroimaging research in human disease as well as disease models. TNL collaborates with an extensive network of laboratories and is committed to scientific training in the field of neuroimaging.
- Advance methodologies for quantifying neurodegenerative processes using Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI).
- Develop analytical frameworks to interface animal and human neuroimaging.
- Enable preclinical diagnosis of dementing diseases by using imaging techniques.
TNL welcomes young scientists and physicians interested in cutting edge integrative neuroimaging of neurodegenerative processes.
TNL is a member of the McGill University Research Centre for Studies in Aging (Neuroinformatic Unit), the Alzheimer’s disease Research Unit and the Douglas Research Institute (Human Neuroreceptor Autoradiography Laboratory). TNL is affiliated with the McConnell Brain Imaging Centre (PET / Short-Lived Radioisotopes), the Douglas Brain Imaging Centre (MRI), and the Stop-AD Centre (Fluid biomarker unit).
We are fortunate to have the support and expertise of the following individuals or institutions.
N.P. Vasavan Nair (Geriatric Psychiatry – primary dementia prevention)
Pierre Etienne (Geriatric Psychiatry – primary dementia prevention)
René Désautels (Geriatric Psychiatry – primary dementia prevention)
Jeffrey Hall (Glutamatergic abnormalities in neurological diseases)
Eliane Kobayashi (Glutamatergic abnormalities in neurological diseases)
John Breitner (Geriatric Psychiatry – primary dementia prevention)
Aurelie Labbe (Epidemiology, Biostatistics & Occupational Health)